Conference Coverage

Conference News Update—Society for Neuroscience


 

In another study, low levels of a cholesterol protein correlated with the severity of MS. The finding suggests that the protein, which protects against inflammation, may protect against developing MS and may help regenerate damaged neurons, said Lidia Gardner, PhD, Assistant Professor of Neurology at the University of Tennessee in Memphis. Cholesterol drugs thus may be potential treatments for MS.

Researchers found that a type of immune system cell directly targets and damages nerve cell axons, just as MS does. This cell may be a target for new disease-modifying therapies. In addition, researchers have found that when exosomes—tiny, naturally occurring nanovesicles—are produced by dendritic cells and applied to the brain, they can deliver a mixture of proteins and RNAs that promote the regeneration of protective myelin sheaths and guard against MS symptoms.

Pages

Recommended Reading

Which Test Best Measures the Severity of Parkinson’s Disease?
MDedge Neurology
New Dystonia Classification Incorporates Phenotype and Etiology
MDedge Neurology
Exercise Therapies Are Among the Most Promising of New Parkinson’s Treatments
MDedge Neurology
Meta-analysis confirms pramipexole calms restless legs
MDedge Neurology
Rotigotine patch improves restless legs symptoms
MDedge Neurology
Vascular risk factors increased likelihood of restless legs syndrome in women
MDedge Neurology
New and Noteworthy Information—October 2013
MDedge Neurology
New and Noteworthy Information—November 2013
MDedge Neurology
Number of restless leg movements during sleep may predict AFib progression
MDedge Neurology
Oxycodone-naloxone nips RLS symptoms after other treatment failures
MDedge Neurology